Aesculap Implant Systems agreed to pay $38.5 million to settle allegations that it marketed its faulty VEGA System® Knee System, which had an elevated rate of premature failure and necessitated costly revision surgeries, and illegally distributed the ELAN-4 Air Drill and the JS Series SterilContainer S2 without required FDA clearance. The company was also accused of knowing about the Vega implant's shortcomings—it could become loose, causing pain—and failing to disclose these issues, alongside allegations of paying unlawful remuneration—consulting payments, travel, and entertainment—to a physician to induce the use of the implants, according to the U.S. Attorney's Office.
U.S. Attorney David Metcalf emphasized the necessity of transparency for medical professionals, stating, "Doctors who implant medical devices need complete and accurate information about those devices to ensure they choose the best and safest options for their patients." The civil settlement includes a non-prosecution agreement for the illegal device distribution, following a previous prison sentence for a company employee who fabricated the FDA clearance documents, as reported by the U.S. Attorney's Office.
This resolution under the False Claims Act resulted from a lawsuit brought by whistleblowers John Marien, Michael McGee, and Brad Stafford, who will receive a portion of the recovery. Assistant Attorney General Brett A. Shumate confirmed the Department of Justice's commitment to accountability, stating, "The Department will hold accountable medical device companies that knowingly sell products prone to failure that present risks to patients and waste taxpayer dollars." This action, handled by the justice system with assistance from governmental bodies, demonstrates a focus on preventing healthcare fraud and protecting patient safety, as stated by the U.S. Attorney's Office.
